HCA Healthcare (NYSE:HCA) Stock Price Expected to Rise, Royal Bank Of Canada Analyst Says

HCA Healthcare (NYSE:HCA) had its target price boosted by research analysts at Royal Bank Of Canada from $482.00 to $525.00 in a research note issued to investors on Friday,MarketScreener reports. The brokerage currently has an “outperform” rating on the stock. Royal Bank Of Canada’s target price would indicate a potential upside of 11.07% from the stock’s current price.

Several other brokerages have also weighed in on HCA. KeyCorp increased their target price on HCA Healthcare from $465.00 to $475.00 and gave the stock an “overweight” rating in a research report on Monday, October 27th. UBS Group lifted their price objective on HCA Healthcare from $495.00 to $525.00 and gave the company a “buy” rating in a research note on Monday, October 27th. Sanford C. Bernstein reissued a “market perform” rating and set a $417.00 target price on shares of HCA Healthcare in a research report on Monday, October 27th. Weiss Ratings reiterated a “buy (b)” rating on shares of HCA Healthcare in a research note on Monday, December 15th. Finally, TD Cowen lifted their target price on shares of HCA Healthcare from $380.00 to $490.00 and gave the company a “buy” rating in a report on Monday, October 27th. Fourteen research analysts have rated the stock with a Buy rating, nine have issued a Hold rating and one has given a Sell rating to the company. Based on data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and an average target price of $479.00.

HCA Healthcare Price Performance

HCA opened at $472.69 on Friday. The business has a 50-day moving average of $470.12 and a two-hundred day moving average of $417.03. HCA Healthcare has a 12 month low of $289.98 and a 12 month high of $520.00. The stock has a market capitalization of $107.87 billion, a price-to-earnings ratio of 18.27, a price-to-earnings-growth ratio of 1.40 and a beta of 1.36.

HCA Healthcare (NYSE:HCA) last released its earnings results on Friday, October 24th. The company reported $6.96 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $5.64 by $1.32. The firm had revenue of $19.16 billion during the quarter, compared to the consensus estimate of $18.55 billion. HCA Healthcare had a net margin of 8.53% and a negative return on equity of 792.25%. HCA Healthcare’s revenue was up 9.6% compared to the same quarter last year. During the same period in the previous year, the firm earned $4.90 earnings per share. HCA Healthcare has set its FY 2025 guidance at 27.000-28.000 EPS. Equities research analysts anticipate that HCA Healthcare will post 24.98 earnings per share for the current year.

Insider Activity

In related news, EVP Michael R. Mcalevey sold 3,892 shares of the business’s stock in a transaction dated Wednesday, November 5th. The stock was sold at an average price of $473.79, for a total value of $1,843,990.68. Following the transaction, the executive vice president owned 3,487 shares in the company, valued at approximately $1,652,105.73. The trade was a 52.74% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. Insiders own 1.30% of the company’s stock.

Institutional Trading of HCA Healthcare

Hedge funds have recently made changes to their positions in the stock. AIA Group Ltd bought a new stake in shares of HCA Healthcare in the third quarter worth $261,000. Mirabella Financial Services LLP increased its position in shares of HCA Healthcare by 112.2% in the 3rd quarter. Mirabella Financial Services LLP now owns 12,715 shares of the company’s stock worth $5,408,000 after purchasing an additional 6,724 shares during the last quarter. Hudson Bay Capital Management LP raised its stake in shares of HCA Healthcare by 154.5% in the 3rd quarter. Hudson Bay Capital Management LP now owns 4,693 shares of the company’s stock valued at $2,000,000 after purchasing an additional 2,849 shares in the last quarter. Allworth Financial LP grew its stake in HCA Healthcare by 20.8% in the third quarter. Allworth Financial LP now owns 1,174 shares of the company’s stock worth $500,000 after purchasing an additional 202 shares in the last quarter. Finally, IFP Advisors Inc raised its stake in HCA Healthcare by 5.5% during the third quarter. IFP Advisors Inc now owns 8,277 shares of the company’s stock valued at $3,528,000 after buying an additional 434 shares in the last quarter. Institutional investors and hedge funds own 62.73% of the company’s stock.

HCA Healthcare Company Profile

HCA Healthcare is a for‑profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.

The company’s core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA’s services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.